Clinical trial · Interventional
Outpatient Radical Prostatectomy - Surgical and Anesthetic Considerations
Outpatient Radical Prostatectomy - Surgical and Anesthetic Considerations - Open Label Randomized Pilot Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Radical prostatectomy has become the gold standard treatment for prostate cancer. Regarding of morbidity of access on open retropubic radical prostatectomy a lot of centers around the world start to develop laparoscopic and robotic approach over the past years. The problems regarding this techniques is that the pure laparoscopic prostatectomy shows a steep learning curve with a high initial complication rate, and the use of robotic assistance surgery despite of lower learning curve is associated with higher surgical supply and operative room costs. These costs may have a significant impact on overall cost of prostate cancer care especially in Brazil. In Brazil, the open route for radical prostatectomy is still the most frequent approach. One of the disadvantages of open prostatectomy from the other surgeries is the longest hospital stay. However, the question of what length of stay after this operation is optimal and necessary is unresolved. In this trial the investigators have compared a randomized group of patients that had discharged on postoperative day 2, 1 and same day surgery. The investigators had intent to evaluate the feasibility of ambulatory open radical prostatectomy (patient discharge in the same day of surgery - average 12 hours of hospitalization) maintaining patient satisfaction and safety.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostatic Neoplasms | Prostate Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (3)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| patient discharge in the day of surgery | Procedure | — | UNRESOLVED |
| patient discharge on postoperative day 1 | Procedure | — | UNRESOLVED |
| patient discharge on postoperative day 2 | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (3)
- type
- ACTIVE_COMPARATOR
- label
- patient discharge on postoperative day 2
- description
- The patient was discharge on postoperative day 2 (as was done routinely)
- interventionNames
- Procedure: patient discharge on postoperative day 2
- type
- EXPERIMENTAL
- label
- patient discharge on postoperative day 1
- description
- The patient was discharge on postoperative day 1
- interventionNames
- Procedure: patient discharge on postoperative day 1
- type
- EXPERIMENTAL
- label
- patient discharge in the day of surgery
- description
Eligibility
Eligibility (as posted)
- Sex
- Male
- Minimum age
- 40 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * clinically localized Prostate Cancer (PCa) * underwent open radical retropubic prostatectomy at Barretos' Cancer Hospital by a single primary surgeon (EFF) * patients which the procedure went without any complications * body mass index ≤ 30 kg/m2 Exclusion Criteria: * Important comorbidities * history of bleeding diathesis * taking blood thinners
References
Publications (0)
Data not yet available